Precision immunotherapy for breast cancer:from biomarkers to clinical practiceOA
Precision immunotherapy for breast cancer:from biomarkers to clinical practice
Jie Mei;Kai Yang;Xinkang Zhang;Xiang Huang;Yongmei Yin
Department of Oncology,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China||The First Clinical Medicine College,Nanjing Medical University,Nanjing 211166,ChinaDepartment of Oncology,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China||The First Clinical Medicine College,Nanjing Medical University,Nanjing 211166,ChinaDepartment of Oncology,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China||The First Clinical Medicine College,Nanjing Medical University,Nanjing 211166,ChinaDepartment of Oncology,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,ChinaDepartment of Oncology,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China||Jiangsu Key Lab of Cancer Biomarkers,Prevention and Treatment,Collaborative Innovation Center for Personalized Cancer Medicine,Nanjing Medical University,Nanjing 211166,China||Collaborative Innovation Center for Cancer Personalized Medicine,Nanjing Medical University,Nanjing 211166,China
《癌症生物学与医学（英文版）》 2026 (3)
320-326,7
This work was supported by the Non-communicable Chronic Diseases National Science and Technology Major Project(Grant No.2025ZD0544003).
评论